Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 51991-983

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 51991-983). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Norepinephrine 01)

Chemical structure of norepinephrine bitartrate showing the molecular arrangement including a benzene ring with hydroxyl groups, an amine side chain, and a bitartrate moiety with carboxyl and hydroxyl groups along with a water molecule (hydrate).*

FDA Label Image

Principal Display Panel (4 mL Vial Carton)

Packaging label for Norepinephrine Bitartrate Injection, USP 4 mg/4 mL (1 mg/mL) concentrate for intravenous use. The label shows the product name, strength, route (IV), quantity (10 x 4 mL single-dose vials), warnings, storage instructions, and manufacturer Breckenridge Pharmaceutical, Inc. The label also includes barcodes and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.